Weight Management
HydroJaro 30mg
R2Β 500
Hydropharma's pre-filled Tirzepatide pen, combining GLP-1 and GIP receptor activity in a single once-weekly formulation. Titrates from 3mg up to a 6mg maintenance dose over four weeks for standard protocols.
- β Dual GLP-1 / GIP receptor agonist
- β 3ml pre-filled pen Β· once weekly
- β Titration: 3mg β 4mg β 5mg β 6mg, maintain 6β8mg
- β Cold chain preserved (2β10Β°C)
48h delivery nationwide Β· Cold chain preserved
Research use only. Not intended to diagnose, treat, cure, or prevent any disease. Consult a licensed professional where applicable.
How It Works
Tirzepatide combines GLP-1 and GIP receptor activity in a single molecule, studied for a broader metabolic-signalling profile than single-receptor agonists.
What to Expect
Dual Receptor Activity
Combines GLP-1 and GIP pathway signalling.
Appetite Regulation
Supports satiety and reduced caloric intake.
Insulin Sensitivity
Studied for glucose-dependent insulin response.
Metabolic Research
Structured optimization protocol support.
Standard Protocol
Administration & Storage
- βKeep refrigerated at 2β10Β°C at all times
- βDo not freeze β freezing degrades peptide structure
- βRe-insert the needle after every use; do not leave the tip screwed on
- βDiscard per the pen's labelled shelf life once in use
Safety Notes
Follow the stated frequency and maximum dose for your protocol β do not exceed without professional guidance.
Consult a licensed healthcare professional before beginning any new protocol, especially alongside existing medication.
You may also like
Weight Management
HydroZempic 5mg
Hydropharma's pre-filled Semaglutide GLP-1 pen. 5ml formulation for once-weekly subcutaneoβ¦48h delivery nationwide
Weight Management
HydroZempic 10mg
Hydropharma's higher-capacity Semaglutide GLP-1 pen. 10ml formulation for extended weekly β¦48h delivery nationwide
Weight Management
HydroJaro 60mg
Hydropharma's high-capacity Tirzepatide pen. 10ml formulation for extended weekly dosing, β¦48h delivery nationwide